eXoZymes, Inc.

Healthcare

NASDAQ:EXOZ · NASDAQ Global Market

Market Cap $65.29M Beta 2.66 P/E (TTM) -6.2

$7.10 -7.79%

-$0.60 today

52W Low $7.08High $18.40

Vol 0.01M · Avg 0.01M

EPS (TTM)-$1.14

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-44.57%

Period High

$16.50

Period Low

$7.09

Latest

$7.10

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Greenwich LifeSciences, Inc.

NASDAQ:GLSI

$353.16M

Surrozen, Inc.

NASDAQ:SRZN

$174.90M

Cognition Therapeutics, Inc.

NASDAQ:CGTX

$89.03M

Oncolytics Biotech Inc.

NASDAQ:ONCY

$80.59M

Tiziana Life Sciences Ltd

NASDAQ:TLSA

$65.37M

Instil Bio, Inc.

NASDAQ:TIL

$53.71M

Estrella Immunopharma, Inc.

ESLA

$45.62M

Tevogen Bio Holdings Inc.

TVGN

$43.84M

Atossa Therapeutics, Inc.

ATOS

$21.18M

Anebulo Pharmaceuticals, Inc.

ANEB

$19.37M

What is the latest EXOZ filing?

The latest filing shown is 424B5 dated Jun 8, 2026.

How many recent filings does EXOZ have?

Intrinsic Alpha currently shows 20 recent filings for EXOZ.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.